SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,954.76 373.76
( 0.48%)

Global Indices

Nasdaq

54,370.92 264.04
(0.49%)

Dow Jones

7,742.03 -15.49
(-0.20%)

Hang Seng

65,663.80 -636.64
(-0.96%)

Nikkei 225

10,873.25 -15.05
(-0.14%)

Forex

USD-INR

95.23 -0.06
(-0.07%)

EUR-INR

109.68 -0.11
(-0.10%)

GBP-INR

127.98 -0.19
(-0.15%)

JPY-INR

0.60 0.00
(-0.60%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Rajnish Wellness Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

541601

INE685Z01033

1.0101443

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

42.64

EPS(TTM)

Face Value()

Div & Yield %

Back

Aurobindo Pharma consolidated net profit rises 25.20% in the June 2026 quarter

Aug 06,2026

Net profit of Aurobindo Pharma rose 25.20% to Rs 1032.56 crore in the quarter ended June 2026 as against Rs 824.75 crore during the previous quarter ended June 2025. Sales rose 16.86% to Rs 9105.82 crore in the quarter ended June 2026 as against Rs 7791.77 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	9105.82	7791.77	17
OPM %	20.64	20.57	-
PBDT	2042.09	1612.50	27
PBT	1555.27	1206.80	29
NP	1032.56	824.75	25

78,954.76 373.76 ( 0.48%)

54,370.92 264.04 (0.49%)

7,742.03 -15.49 (-0.20%)

65,663.80 -636.64 (-0.96%)

10,873.25 -15.05 (-0.14%)

95.23 -0.06 (-0.07%)

109.68 -0.11 (-0.10%)

127.98 -0.19 (-0.15%)

0.60 0.00 (-0.60%)